Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-01 Purchase | 2022-03-01 5:58 pm | Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer | 76,686 | $0.23 | $17,638 | 100,000 (Direct) | View |
| 2022-02-04 Purchase | 2022-02-07 5:09 pm | Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer | 23,314 | $0.23 | $5,362 | 23,314 (Direct) | View |
| 2022-01-12 Purchase | 2022-01-26 4:13 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 100,000 | $0.2152 | $21,520 | 2,017,006 (Direct) | View |
| 2021-05-17 Sale | 2021-05-17 7:13 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,186 | $0.89 | $3,726 | 316,292 (Direct) | View |
| 2021-05-17 Sale | 2021-05-17 7:12 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 860 | $0.89 | $765 | 41,754 (Direct) | View |
| 2021-02-16 Sale(A) | 2021-04-16 4:11 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,144 | $1.72 | $7,128 | 244,628 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-11(A) Option Award | 2023-01-17 4:13 pm | N/A 2033-01-10 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 45,000 | $0 | 45,000 (Direct) | View |
| 2023-01-11 Option Award | 2023-01-17 4:11 pm | N/A 2033-01-10 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-01-11 Option Award | 2023-01-17 4:10 pm | N/A 2033-01-10 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2023-01-11 Option Award | 2023-01-17 4:07 pm | N/A 2033-01-10 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:24 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:21 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:19 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | Huang Alice Shih-hou Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:19 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | Nunn Jason Raleigh Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:18 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:17 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director | 90,000 | $0 | 90,000 (Indirect) | View |
| 2022-06-09 Option Award | 2022-06-10 4:16 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:16 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | Simeonidis Simos Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:15 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | Witz Pascale Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-11 4:54 pm | N/A 2030-01-20 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-11 4:34 pm | N/A 2030-01-20 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-11 4:31 pm | N/A 2030-01-20 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 70,000 | $0 | 70,000 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-26 4:14 pm | N/A 2032-01-11 | Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-26 4:13 pm | N/A 2032-01-11 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 1,600,000 | $0 | 2,017,006 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-26 4:12 pm | N/A 2032-01-11 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA Chief Financial Officer | 480,000 | $0 | 480,000 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-26 4:11 pm | N/A 2032-01-11 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 480,000 | $0 | 480,000 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-01 4:12 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 2,222,222 | $0.36 | 5,061,929 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 5:17 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | Simeonidis Simos Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:46 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | Witz Pascale Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:45 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:44 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:43 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:43 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | Nunn Jason Raleigh Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:42 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | Huang Alice Shih-hou Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:40 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:39 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-04-14 Conversion | 2021-04-16 4:12 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 83,435 | $0 | 320,478 (Indirect) | View |